Dataset from An Open-Label Study to Assess the Effects of BG00012 on Lymphocyte Subsets in Subjects With Relapsing-Remitting Multiple Sclerosis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007234
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to evaluate the effect of BG00012 on lymphocyte subset
counts during the first year of treatment in subjects with relapsing-remitting multiple
sclerosis (RRMS). A secondary objective is to evaluate the pharmacodynamic effect on absolute
lymphocyte counts (ALCs) and immunoglobulins (Igs) during the first year of treatment.
创建时间：
2025-04-19
